Browsing Centre for Immunobiology by Subject "Randomised controlled trial"
Now showing items 1-1 of 1
-
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
(BioMed Central, 2021-01-21)BACKGROUND: Ending the global tuberculosis (TB) epidemic requires a focus on treating individuals with latent TB infection (LTBI) to prevent future cases. Promising trials of shorter regimens have shown them to be effective ...